Humira: The Most Financially Successful Drug Ever!

What the low impact of Humira biosimilars teaches us about drug prices

The Humira Alternative for Inflammation – Dr. Berg On Rheumatoid Arthritis Symptoms

Three Biosimilars on the Market and Hadlima To Come

EP396: How to Answer This Question: Will Humira® Biosimilars Reduce Drug Spend? With Anna Hyde

Development of Humira (adalimumab) - monoclonal antibody manufacturing with bioreactor technology

Webinar: Biosimilars Impact and Implications

Hadlima, on the Market in 27 Countries, ‘Has Experience,’ Says Samsung Bioepis Executive

The End of Humira’s $200 Billion Drug Monopoly

Humira Patent Expiration: What are the Consequences on AbbVie Stock?

[STAT Virtual Event] The State of Biosimilars: What to Watch

Running with Arthritis Update - Cortisone, Periodic Fevers, Humira, and Coping

Humira: 15 Side Effects happening to me.

Rheology of Highly Concentrated Antibody Solutions

Treating Autoimmune Inflammation: oligoarticular JIA/uveitis; Humira, Methotrexate, Steroids, NSAIDs

The Pharma Flash - Week of July 21st, 2023

Bioavailability & Bioequivalence

Humira + Update

Inflation Re-Emergence | AbbVie's Humira, Disney Streaming, Intel's Issues | Triple Play Ep. 7

Therapeutic Innovations The Game Changers